Crossmark

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients

Published Online: 2020-07-16

Published Print: 2020-12

Authors

Zhang, Xilin

Jiang, Yan

Yu, Huanming

Xia, Hui

Wang, Xiang http://orcid.org/0000-0002-3531-5016
Funding

Funding for this research was provided by:

Zhejiang Province Science and Technology Department of Public Welfare Project (LGF18H160019, LGF20H160016)

the Scientific Technology Projects of Health and Medicine of Zhejiang Province (WKJ-ZJ-1830, 2019KY207)

Huzhou Science and Technology Fund (2017GY33)
License Information

Text and Data Mining valid from 2020-07-16

Version of Record valid from 2020-07-16
More Information

Article History

Received: 17 February 2020

Accepted: 3 July 2020

First Online: 16 July 2020

Competing interest

: All authors declared no conflicts of interest with respect to the research, authorship, and/or publication of this article.

: This study was approved by the ethics committee of the First People’s Hospital of Huzhou (grant no. 2015-012).

: The informed consent signature was provided by all patients.

Document is current